PA
THC icon

PharVision Advisers’s Tenet Healthcare THC Stock Holding History

PharVision Advisers’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,718
Closed -$231K – 426
2025
Q1 		$231K Sell
1,718
-1,124
-40% -$148K 0.32% 154
2024
Q4 		$359K Buy
+2,842
New +$423K 0.3% 101

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PharVision Advisers's THC Position: Q2 2025 in Review

PharVision Advisers sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 1,718 shares — an estimated $231K sold.

PharVision Advisers first reported a position in THC in Q4 2024 and held it in 2 quarters. The position peaked at $359K in Q4 2024. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • PharVision Advisers reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 1,718 Tenet Healthcare shares in Q2 2025, an estimated $231K.
  • PharVision Advisers first reported a position in Tenet Healthcare in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Tenet Healthcare position peaked at $359K in Q4 2024.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.